GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jul 24, 2014

Early Warning of Any Cancer

Immunosignature analysis, a multiplexed means of profiling circulating antibodies, reveals patterns unique to specific cancers.

Early Warning of Any Cancer

Immunosignaturing could enable early cancer detection and deliver universality—a single platform could be used for any cancer. [Biodesign Institute, Arizona State University]

  • The reductionist approach to cancer detection—scrutinizing a particular set of biomarkers for each cancer—is fraught with obstacles. It may not be possible, in many ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

    • Do not put any letters or characters here if you are not a spy program.
    •  

Get GEN Select Access Now



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Connectomics Advocacy

How might connectomics maintain lasting support?